These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Malignancies after pediatric solid organ transplantation. Robinson C; Chanchlani R; Kitchlu A Pediatr Nephrol; 2021 Aug; 36(8):2279-2291. PubMed ID: 33057766 [TBL] [Abstract][Full Text] [Related]
11. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality. Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147 [TBL] [Abstract][Full Text] [Related]
12. Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review. Ekman-Joelsson BM; Wåhlander H; Synnergren M; Sager M; Mellgren K Cardiol Young; 2017 Nov; 27(9):1823-1831. PubMed ID: 28780922 [TBL] [Abstract][Full Text] [Related]
13. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Shapiro R; Nalesnik M; McCauley J; Fedorek S; Jordan ML; Scantlebury VP; Jain A; Vivas C; Ellis D; Lombardozzi-Lane S; Randhawa P; Johnston J; Hakala TR; Simmons RL; Fung JJ; Starzl TE Transplantation; 1999 Dec; 68(12):1851-4. PubMed ID: 10628763 [TBL] [Abstract][Full Text] [Related]
15. A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders. Caillard S; Cellot E; Dantal J; Thaunat O; Provot F; Janbon B; Buchler M; Anglicheau D; Merville P; Lang P; Frimat L; Colosio C; Alamartine E; Kamar N; Heng AE; Durrbach A; Moal V; Rivalan J; Etienne I; Peraldi MN; Moreau A; Moulin B; Clin J Am Soc Nephrol; 2017 Oct; 12(10):1663-1670. PubMed ID: 28818847 [TBL] [Abstract][Full Text] [Related]
16. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience. Wasson S; Zafar MN; Best J; Reddy HK J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222 [TBL] [Abstract][Full Text] [Related]
17. [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience]. Franco A; Jiménez L; Sillero C; Trigueros M; González D; Alcaraz E; Olivares J Nefrologia; 2010; 30(6):669-75. PubMed ID: 21113217 [TBL] [Abstract][Full Text] [Related]
18. Emerging Concepts in Managing Malignancy in Kidney Transplant Patients. Schreiber B; Abdelrahim M; Abudayyeh A; Murakami N Semin Nephrol; 2022 Jan; 42(1):63-75. PubMed ID: 35618396 [TBL] [Abstract][Full Text] [Related]
19. Post-renal transplant malignancies: Opportunities for prevention and early screening. Turshudzhyan A Cancer Treat Res Commun; 2021; 26():100283. PubMed ID: 33338850 [TBL] [Abstract][Full Text] [Related]
20. [Development of primary malignancies after liver and kidney transplantation and the treatment approach]. Bechstein WO; Dette K; Golling M; Wullstein Ch Kongressbd Dtsch Ges Chir Kongr; 2002; 119():398-404. PubMed ID: 12704897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]